Cypress Capital Group’s Colgate-Palmolive CL Stock Holding History

Cypress Capital Group’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04M	Buy	12,228 +1,015	+9%	+$90.5K	0.12%	127
2025 Q4	$886K	Sell	11,213 -279	-2%	-$21.9K	0.1%	128
2025 Q3	$919K	Sell	11,492 -5,239	-31%	-$447K	0.11%	125
2025 Q2	$1.52M	Sell	16,731 -355	-2%	-$32.4K	0.19%	100
2025 Q1	$1.6M	Sell	17,086 -12,561	-42%	-$1.12M	0.21%	93
2024 Q4	$2.7M	Buy	29,647 +3,307	+13%	+$316K	0.33%	67
2024 Q3	$2.73M	Sell	26,340 -317	-1%	-$32.3K	0.31%	76
2024 Q2	$2.59M	Sell	26,657 -948	-3%	-$87.5K	0.31%	76
2024 Q1	$2.49M	Buy	27,605 +1,358	+5%	+$115K	0.3%	81
2023 Q4	$2.09M	Sell	26,247 -514	-2%	-$38.6K	0.27%	86
2023 Q3	$1.9M	Sell	26,761 -1,292	-5%	-$96.6K	0.27%	85
2023 Q2	$2.16M	Sell	28,053 -555	-2%	-$43K	0.31%	73
2023 Q1	$2.15M	Sell	28,608 -5,853	-17%	-$435K	0.33%	68
2022 Q4	$2.72M	Sell	34,461 -1,421	-4%	-$107K	0.41%	66
2022 Q3	$2.52M	Sell	35,882 -449	-1%	-$35.2K	0.42%	64
2022 Q2	$2.91M	Sell	36,331 -739	-2%	-$57.8K	0.44%	66
2022 Q1	$2.81M	Buy	37,070 +1,364	+4%	+$108K	0.35%	82
2021 Q4	$3.05M	Sell	35,706 -2,497	-7%	-$195K	0.38%	73
2021 Q3	$2.89M	Sell	38,203 -2,376	-6%	-$189K	0.39%	72
2021 Q2	$3.3M	Buy	40,579 +1,292	+3%	+$106K	0.45%	65
2021 Q1	$3.1M	Buy	39,287 +1,848	+5%	+$145K	0.44%	64
2020 Q4	$3.2M	Buy	37,439 +742	+2%	+$61.4K	0.48%	58
2020 Q3	$2.83M	Buy	36,697 +155	+0.4%	+$11.8K	0.47%	59
2020 Q2	$2.68M	Buy	36,542 +1,965	+6%	+$140K	0.49%	59
2020 Q1	$2.29M	Buy	34,577 +2,599	+8%	+$183K	0.53%	58
2019 Q4	$2.2M	Sell	31,978 -749	-2%	-$51.1K	0.39%	70
2019 Q3	$2.41M	Sell	32,727 -1,587	-5%	-$115K	0.46%	68
2019 Q2	$2.46M	Sell	34,314 -3,000	-8%	-$213K	0.49%	63
2019 Q1	$2.56M	Buy	37,314 +1,600	+4%	+$103K	0.52%	62
2018 Q4	$2.13M	Sell	35,714 -1,091	-3%	-$68.3K	0.49%	64
2018 Q3	$2.46M	Sell	36,805 -700	-2%	-$46.6K	0.47%	68
2018 Q2	$2.43M	Sell	37,505 -540	-1%	-$35.3K	0.5%	67
2018 Q1	$2.73M	Sell	38,045 -2,300	-6%	-$166K	0.57%	60
2017 Q4	$3.04M	Sell	40,345 -3,641	-8%	-$266K	0.63%	53
2017 Q3	$3.2M	Sell	43,986 -45	-0.1%	-$3.24K	0.68%	53
2017 Q2	$3.26M	Sell	44,031 -2,020	-4%	-$150K	0.72%	50
2017 Q1	$3.37M	Sell	46,051 -282	-0.6%	-$19.7K	0.79%	46
2016 Q4	$3.03M	Sell	46,333 -635	-1%	-$43.5K	0.72%	50
2016 Q3	$3.48M	Buy	46,968 +525	+1%	+$38.8K	0.83%	42
2016 Q2	$3.4M	Sell	46,443 -433	-0.9%	-$30.8K	0.8%	47
2016 Q1	$3.31M	Sell	46,876 -552	-1%	-$36.7K	0.81%	44
2015 Q4	$3.16M	Sell	47,428 -3,500	-7%	-$233K	0.76%	48
2015 Q3	$3.23M	Sell	50,928 -364	-0.7%	-$23.8K	0.8%	46
2015 Q2	$3.35M	Buy	51,292 +560	+1%	+$38K	0.77%	48
2015 Q1	$3.52M	Buy	50,732 +3,323	+7%	+$230K	0.8%	47
2014 Q4	$3.28M	Buy	47,409 +6,754	+17%	+$456K	0.76%	48
2014 Q3	$2.65M	Sell	40,655 -400	-1%	-$26.4K	0.63%	57
2014 Q2	$2.8M	Buy	41,055 +3,545	+9%	+$238K	0.66%	54
2014 Q1	$2.43M	Hold	37,510	–	–	0.6%	58
2013 Q4	$2.45M	Sell	37,510 -6,945	-16%	-$444K	0.6%	57
2013 Q3	$2.64M	Sell	44,455 -15,177	-25%	-$899K	0.65%	57
2013 Q2	$3.42M	Buy	+59,632	New	+$3.54M	0.71%	55

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cypress Capital Group's CL Position: Q1 2026 in Review

Cypress Capital Group increased its Colgate-Palmolive (CL) stake by 9.1% in Q1 2026, buying an estimated $90.5K and bringing the position to 12,228 shares worth $1.04M. The position accounts for 0.12% of the portfolio, ranked #127.

Cypress Capital Group first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.52M in Q1 2015. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Cypress Capital Group held 12,228 shares of Colgate-Palmolive worth $1.04M as of Q1 2026.
Cypress Capital Group bought 1,015 Colgate-Palmolive shares in Q1 2026, an estimated $90.5K.
Colgate-Palmolive made up 0.12% of Cypress Capital Group's portfolio in Q1 2026, its #127 holding.
Cypress Capital Group first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
Cypress Capital Group's Colgate-Palmolive position peaked at $3.52M in Q1 2015.
1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Cypress Capital Group's 13F filing for Q1 2026, filed 15 May 2026.